EFFET DU VERALIPRIDE SUR LES TAUX DE LH, FSH ET PRL ET SUR LE SYNDROME CLIMATERIQUE

Translated title of the contribution: Effect of veralipride on LH, FSH and PRL levels and on the climacteric syndrome

L. De Cecco, P. L. Venturini, M. P. Alibrandi

Research output: Contribution to journalArticle

Abstract

21 women with menopausal disorders were given veralipride, which is a benzamide derivative having a central anti-dopaminergic action. The LH, and PRL plasma levels were controlled before and after treatment. Treatment, using veralipride at a daily dose of 100 mg for 20 days, improved the climacteric syndrome, and, in particular, the sudden hot flushes. The FSH plasma levels remained unchanged, the LH levels were reduced, although they remained high, and the PRL levels increased during the course of the treatment.

Translated title of the contributionEffect of veralipride on LH, FSH and PRL levels and on the climacteric syndrome
Original languageFrench
Pages (from-to)691-694
Number of pages4
JournalRevue Francaise de Gynecologie et d'Obstetrique
Volume76
Issue number10
Publication statusPublished - 1981

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Effect of veralipride on LH, FSH and PRL levels and on the climacteric syndrome'. Together they form a unique fingerprint.

  • Cite this